Mereo BioPharma Group plc

Declaration of Voting Results & Voting Rights Announcements • Jun 9, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7671A

Mereo BioPharma Group plc

09 June 2016

Mereo BioPharma Group plc

Grant of Options

Mereo BioPharma Group plc ("Mereo" or the "Company") (AIM: MPH), a UK-based specialty biopharmaceutical company, today announces that it has granted nil-cost options over a total of 695,700 ordinary shares of £0.003 each in the capital of the Company ("Ordinary Shares") under the Long Term Incentive Plan (the "Options"). The Options have been granted to certain directors of the Company as follows:

Name	No. of Options granted
Denise Scots-Knight (Chief Executive Officer)	461,538
Richard Bungay (Chief Financial Officer and Chief Operating Officer)	234,162

These Options form the respective director's long-term incentive component of their remuneration for the 2016 financial year.

The vesting of the Options is conditional on the continued employment of the option holder as well as the satisfaction of the following performance conditions:

1.   75% of the Options will be subject to a number of share price growth targets, measured over three to five years; and

2.   25% of the Options will be subject to strategic targets, measured over five years.

The Options will vest to the extent the performance conditions have been satisfied, after which they will normally be exercisable for a period of one year.

Enquiries:

Mereo BioPharma Group plc	+44 (0)333 023 7319
Denise Scots-Knight, Chief Executive Officer
Richard Bungay, Chief Financial Officer & COO
Cantor Fitzgerald Europe (Nominated Adviser and Broker)	+44 (0)20 7894 7000
Phil Davies
Will Goode
Rick Thompson
Callum Butterfield
RBC Capital Markets (Joint Broker)	+44 (0)20 7653 4000
Paul Tomasic
Rupert Walford
Thomas Stockman
Laura White
FTI Consulting (Public Relations Adviser)	+44 (0)20 3727 1000
Ben Atwell
Simon Conway
Brett Pollard

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLKLFBQQFFBBE